Inventor · disambiguated record
Philippe Diaz
Also filed as: DIAZ PHILIPPE · DIAZ PHILIPPE FREIRE
26 granted patents·12 pending applications·217 citations·filing 1996–2022
95Inventor score
Files withGALDERMA RES & DEV14CIRD GALDERMA3CLEVELAND CLINIC FOUND3CLEVELAND CLINIC FOUNDATION3ATTALA MOHAMED NAGUIB2
Top patents by PatentIndex Score
38 records- 0187US9394267B2Heterocyclic modulators of cannabinoid receptorsCLEVELAND CLINIC FOUNDATION·Filed 2013·Granted Jul 19, 2016·4 cites·1 claims
- 0285US8206144B2Transfer device and linear-type apparatus for the manufacture of containersNG KHENG JOO·Filed 2008·Granted Jun 26, 2012·26 cites·20 claims
- 0383US5942531APhenolic/naphtholic retinoids for promoting skin/exoskeleton pigmentationCIRD·Filed 1998·Granted Aug 24, 1999·55 cites·23 claims
- 0482US9079854B2Hydrazone modulators of cannabinoid receptorsCLEVELAND CLINIC FOUNDATION·Filed 2012·Granted Jul 14, 2015·2 cites·6 claims
- 0579US7592478B2Ligand antagonists of RAR receptors and pharmaceutical/cosmetic applications thereofGALDERMA RES & DEV·Filed 2007·Granted Sep 22, 2009·5 cites·37 claims
- 0678US8440832B2Heterocyclic modulators of cannabinoid receptorsATTALA MOHAMED NAGUIB·Filed 2008·Granted May 14, 2013·4 cites·1 claims
- 0778US8309595B2Hydrazone modulators of cannabinoid receptorsATTALA MOHAMED NAGUIB·Filed 2008·Granted Nov 13, 2012·4 cites·13 claims
- 0874US11420967B2Modified carbazoles as therapeutic agentsUNIV WASHINGTON·Filed 2019·Granted Aug 23, 2022·1 cites·24 claims
- 0974US5849798APolyaromatic heterocyclic compounds and pharmaceutical/cosmetic compositions comprised thereofCIRD GALDERMA·Filed 1996·Granted Dec 15, 1998·33 cites·37 claims
- 1068US6194450B1Polyaromatic heterocyclic compounds and pharmaceutical compositions comprised thereofGALDERMA RECH DERMATOLOGIQUE·Filed 1998·Granted Feb 27, 2001·23 cites·10 claims
- 1167US5981776AHeterocyclic biaryl compounds, pharmaceutical and cosmetic compositions containing them and uses thereofCIRD GALDERMA·Filed 1997·Granted Nov 9, 1999·22 cites·27 claims
- 1267US2018200225A1Hydrazone modulators of cannabinoid receptorsCLEVELAND CLINIC FOUND·Filed 2018·Application pending·0 cites
- 1366US6441010B2Bi-aromatic compounds linked via a heteroethynylene radical, and pharmaceutical and cosmetic compositions containing themGALDERMA RES & DEV·Filed 2001·Granted Aug 27, 2002·2 cites·22 claims
- 1464US6921777B2Heteroethynylenic compounds and pharmaceutical and cosmetic compositions containing themGALDERMA RES & DEV·Filed 2002·Granted Jul 26, 2005·1 cites·49 claims
- 1564US2022380367A1Modified carbazoles as therapeutic agentsUNIV WASHINGTON·Filed 2022·Application pending·0 cites
- 1661US2017231953A1Hydrazone modulators of cannabinoid receptorsCLEVELAND CLINIC FOUND·Filed 2017·Application pending·0 cites
- 1760US6818666B2Bi-aromatic compounds linked via a heteroethylene radical, and pharmaceutical and cosmetic compositions using themGALDERMA RES & DEV·Filed 2002·Granted Nov 16, 2004·2 cites·20 claims
- 1859US9656957B2Hydrazone modulators of cannabinoid receptorsCLEVELAND CLINIC FOUND·Filed 2015·Granted May 23, 2017·0 cites·6 claims
- 1952US6258775B1Bi-aromatic compounds, pharmaceutical and cosmetic compositions containing same and usesGALDERMA RECH DERMATOLOGIQUE·Filed 1998·Granted Jul 10, 2001·10 cites·25 claims
- 2051US2006014803A1Diarylselenide compounds and their use in human or veterinary medicine and in cosmeticsGALDERMA RES & DEV·Filed 2005·Application pending·0 cites
- 2151US2004162339A1Heterocyclic biaryl compounds, pharmaceutical and cosmetic compositions containing them and uses thereofFiled 2004·Application pending·0 cites
- 2248US10227332B2T-type calcium channel modulator and uses thereofUTI LP·Filed 2015·Granted Mar 12, 2019·0 cites·13 claims
- 2348US7348449B2Ligand antagonists of RAR receptors and pharmaceutical/cosmetic applications thereofGALDERMA RES & DEV·Filed 2005·Granted Mar 25, 2008·0 cites·61 claims
- 2448US6444709B1Heteroethylene compounds and pharmaceutical and cosmetic compositions containing sameGALDERMA RES & DEV·Filed 1999·Granted Sep 3, 2002·6 cites·16 claims
- 2546US9339486B2Heterocyclic modulators of cannabinoid receptorsCLEVELAND CLINIC FOUNDATION·Filed 2015·Granted May 17, 2016·0 cites·2 claims
- 2646US7829588B2Modulators of the PPAR-type receptors and pharmaceutical/cosmetic applications thereofGALDERMA RES & DEV·Filed 2006·Granted Nov 9, 2010·0 cites·17 claims
- 2746US2012039804A1Novel Tricyclic Modulators of Cannabinoid ReceptorsDIAZ PHILIPPE·Filed 2011·Application pending·0 cites
- 2846US2017096426A1Novel Tricyclic Modulators of Cannabinoid ReceptorsTHE UNIV OF MONTANA·Filed 2016·Application pending·0 cites
- 2945US2006058351A1Novel ligands that modulate LXR-type receptors and cosmetic/pharmaceutical applications thereofGALDERMA RES & DEV·Filed 2005·Application pending·0 cites
- 3044US5905088AHeterocyclic biaryl compounds and pharmaceutical/cosmetic compositions comprised thereofCIRD GALDERMA·Filed 1997·Granted May 18, 1999·6 cites·55 claims
- 3144US2008004274A1Novel biaromatic compounds that modulate PPAR type receptors and cosmetic/pharmaceutical compositions comprised thereofGALDERMA RES & DEV·Filed 2007·Application pending·0 cites
- 3241US6201019B1Bi-aromatic compounds bound by a heteroethynylene radical and pharmaceutical and cosmetic compositions containing sameGALDERMA RES & DEV·Filed 1998·Granted Mar 13, 2001·3 cites·23 claims
- 3339US2015018369A1Compositions and Methods for Treating Malignant AstrocytomasUNIV WASHINGTON CT COMMERCIALI·Filed 2013·Application pending·0 cites
- 3439US2006052627A1Novel modulators of the PPAR-type receptors and cosmetic/pharmaceutical compositions comprised thereofGALDERMA RES & DEV·Filed 2005·Application pending·0 cites
- 3538US2006035969A1Novel modulators of the PPAR-type receptors and cosmetic/pharmaceutical compositions comprised thereofGALDERMA RES & DEV·Filed 2005·Application pending·0 cites
- 3637US6992094B1Diarylselenide compounds and their use in human or veterinary medicine and in cosmeticsGALDERMA RES & DEV·Filed 1999·Granted Jan 31, 2006·3 cites·8 claims
- 3736US9963439B2Specific inhibitors of cytochrome P450 26 retinoic acid hydroxylaseUNIV WASHINGTON THROUGH ITS CENTER FOR COMMERCIALIZATION·Filed 2014·Granted May 8, 2018·0 cites·53 claims
- 3832US6030952ABenzofuran-acrylic acid derivatives and their use as modulators of RXRs or RARs receptorsRECH DERMATOLOGIOUES GALDERMA·Filed 1997·Granted Feb 29, 2000·5 cites·21 claims
Join the waitlist — get patent alerts
Get an alert when Philippe Diaz files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →